Literature DB >> 20173116

Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit.

Michelle Perugini1, Anna L Brown, Diana G Salerno, Grant W Booker, Cvetan Stojkoski, Timothy R Hercus, Angel F Lopez, Margaret L Hibbs, Thomas J Gonda, Richard J D'Andrea.   

Abstract

Granulocyte/macrophage colony-stimulating factor promotes growth, survival, differentiation, and activation of normal myeloid cells and plays an important role in myeloid leukemias. The GM-CSF receptor (GMR) shares a signaling subunit, beta(c), with interleukin-3 and interleukin-5 receptors and has recently been shown to induce activation of Janus kinase 2 (JAK2) and downstream signaling via formation of a unique dodecameric receptor complex. In this study we use 2 activated beta(c) mutants that display distinct signaling capacity and have differential requirements for the GMR alpha-subunit (GMR-alpha) to dissect the signaling pathways associated with the GM-CSF response. The V449E transmembrane mutant selectively activates JAK2/signal transducer and activator of transcription 5 and extracellular signal-regulated kinase (ERK) pathways, resulting in a high level of sensitivity to JAK and ERK inhibitors, whereas the extracellular mutant (FIDelta) selectively activates the phosphoinositide 3-kinase/Akt and IkappaKbeta/nuclear factorkappaB pathways. We also demonstrate a novel and direct interaction between the SH3 domains of Lyn and Src with a conserved proline-rich motif in GMR-alpha and show a selective requirement for Src family kinases by the FIDelta mutant. We relate the nonoverlapping nature of signaling by the activated mutants to the structure of the unique GMR complex and propose alternative modes of receptor activation acting synergistically in the mature liganded receptor complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173116      PMCID: PMC2858480          DOI: 10.1182/blood-2009-08-235846

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  Overlapping motifs in the membrane-proximal region of cytokine receptor accessory and signaling subunits.

Authors:  Richard J D'Andrea; Timothy J Sadlon; Thomas J Gonda
Journal:  Cytokine Growth Factor Rev       Date:  2004 Apr-Jun       Impact factor: 7.638

Review 2.  Fluorescence polarization assay to quantify protein-protein interactions.

Authors:  Sang-Hyun Park; Ronald T Raines
Journal:  Methods Mol Biol       Date:  2004

3.  Mapping the intracytoplasmic regions of the alpha granulocyte-macrophage colony-stimulating factor receptor necessary for cell growth regulation.

Authors:  A Polotskaya; Y Zhao; M B Lilly; A S Kraft
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

4.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

5.  Single cell profiling of potentiated phospho-protein networks in cancer cells.

Authors:  Jonathan M Irish; Randi Hovland; Peter O Krutzik; Omar D Perez; Øystein Bruserud; Bjørn T Gjertsen; Garry P Nolan
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

6.  The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of bcl-2.

Authors:  Mark A Guthridge; Emma F Barry; Fernando A Felquer; Barbara J McClure; Frank C Stomski; Hayley Ramshaw; Angel F Lopez
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113

7.  A critical role for the cytoplasmic domain of the granulocyte-macrophage colony-stimulating factor alpha receptor in mediating cell growth.

Authors:  A Polotskaya; Y Zhao; M L Lilly; A S Kraft
Journal:  Cell Growth Differ       Date:  1993-06

8.  GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with IkappaB kinase beta.

Authors:  Karin Ebner; Alexander Bandion; Bernd R Binder; Rainer de Martin; Johannes A Schmid
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113

9.  JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region.

Authors:  F W Quelle; N Sato; B A Witthuhn; R C Inhorn; M Eder; A Miyajima; J D Griffin; J N Ihle
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

10.  Deficiencies of GM-CSF and interferon gamma link inflammation and cancer.

Authors:  Thomas Enzler; Silke Gillessen; John P Manis; David Ferguson; James Fleming; Frederick W Alt; Martin Mihm; Glenn Dranoff
Journal:  J Exp Med       Date:  2003-05-05       Impact factor: 14.307

View more
  22 in total

1.  NF-κB inhibitors impair lung epithelial tight junctions in the absence of inflammation.

Authors:  Christina Ward; Barbara Schlingmann; Arlene A Stecenko; David M Guidot; Michael Koval
Journal:  Tissue Barriers       Date:  2015-04-03

Review 2.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

3.  High CD123 levels enhance proliferation in response to IL-3, but reduce chemotaxis by downregulating CXCR4 expression.

Authors:  Nicole L Wittwer; Gabriela Brumatti; Ceilidh Marchant; Jarrod J Sandow; Melanie K Pudney; Mara Dottore; Richard J D'Andrea; Angel F Lopez; Paul G Ekert; Hayley S Ramshaw
Journal:  Blood Adv       Date:  2017-06-20

4.  Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation.

Authors:  Haijiao Zhang; Cody Coblentz; Kevin Watanabe-Smith; Sophie Means; Jasmine Means; Julia E Maxson; Jeffrey W Tyner
Journal:  J Biol Chem       Date:  2018-03-23       Impact factor: 5.157

5.  Myelo-erythroid commitment after burn injury is under β-adrenergic control via MafB regulation.

Authors:  Shirin Hasan; Nicholas B Johnson; Michael J Mosier; Ravi Shankar; Peggie Conrad; Andrea Szilagyi; Richard L Gamelli; Kuzhali Muthumalaiappan
Journal:  Am J Physiol Cell Physiol       Date:  2016-12-28       Impact factor: 4.249

Review 6.  Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.

Authors:  Palash Bhattacharya; Isadore Budnick; Medha Singh; Muthusamy Thiruppathi; Khaled Alharshawi; Hatem Elshabrawy; Mark J Holterman; Bellur S Prabhakar
Journal:  J Interferon Cytokine Res       Date:  2015-03-24       Impact factor: 2.607

7.  Structural basis of interleukin-5 dimer recognition by its α receptor.

Authors:  Seisuke Kusano; Mutsuko Kukimoto-Niino; Nobumasa Hino; Noboru Ohsawa; Masashi Ikutani; Satoshi Takaki; Kensaku Sakamoto; Miki Hara-Yokoyama; Mikako Shirouzu; Kiyoshi Takatsu; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2012-04-23       Impact factor: 6.725

8.  Cytokine receptor signaling activates an IKK-dependent phosphorylation of PUMA to prevent cell death.

Authors:  J J Sandow; A M Jabbour; M R Condina; C P Daunt; F C Stomski; B D Green; C D Riffkin; P Hoffmann; M A Guthridge; J Silke; A F Lopez; P G Ekert
Journal:  Cell Death Differ       Date:  2011-10-14       Impact factor: 15.828

Review 9.  Src-family and Syk kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk.

Authors:  Clifford A Lowell
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-03-01       Impact factor: 10.005

Review 10.  G-CSF and GM-CSF in Neutropenia.

Authors:  Hrishikesh M Mehta; Michael Malandra; Seth J Corey
Journal:  J Immunol       Date:  2015-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.